The Pharma Trends You Need To Know: A CDMO’s Perspective

Companies must understand how today’s new pharmaceutical landscape is causing a dramatic shift in how we plan for and execute drug development and manufacturing.

Strategies For API Solubility And Bioavailability Enhancement: Selecting Technologies And Excipients

Bypassing conventional trial-and-error methods for solubility challenges and excipient selection can eliminate unnecessary testing, improve the efficacy of formulations, and increase overall speed-to-market.

Collegium Pharmaceutical's Approach To Abuse Deterrence Breaks New Ground

To address the ongoing public health crisis related to opioid abuse, Xtampza® ER has been developed to resist the ability of abusers to tamper with the product and alter the route of administration.

What’s The Best Path For Your Low Soluble Molecule?

A tale of two molecules, both designed to treat the same condition, both with solubility challenges. Two biopharma companies racing to be first.

Drug Development: Strategies And Solutions

Whether your company is built on a single molecule or you’re a global pharmaceutical leader, you need fast, cost-effective, and scientifically based insights during early-phase development. Leverage an innovative partner with proven expertise in early development to ensure quick problem solving, speed, and results.